Patients with DM+HT, as compared to the group without DM or HT, presented, after statistical adjustment for BMI, higher oxLDL/LDLc, adiponectin, leptin, and MID-A percentage and lower TC, HDLc, LDLc, and CRP. The gene discussed is ADIPOQ; the disease is hematocrit.